| Literature DB >> 36159471 |
Hongkun Xue1, Pengcheng Li2, Jiayue Bian3, Yuchao Gao1, Yumei Sang1, Jiaqi Tan1,4.
Abstract
Traditional Chinese medicines (TCM), as the unique natural resource, are rich in polysaccharides, polyphenols, proteins, amino acid, fats, vitamins, and other components. Hence, TCM have high medical and nutritional values. Polysaccharides are one of the most important active components in TCM. Growing reports have indicated that TCM polysaccharides (TCMPs) have various biological activities, such as antioxidant, anti-aging, immunomodulatory, hypoglycemic, hypolipidemic, anti-tumor, anti-inflammatory, and other activities. Hence, the research progresses and future prospects of TCMPs must be systematically reviewed to promote their better understanding. The aim of this review is to provide comprehensive and systematic recombinant information on the extraction, purification, structure, chemical modification, biological activities, and potential mechanism of TCMPs to support their therapeutic effects and health functions. The findings provide new valuable insights and theoretical basis for future research and development of TCMPs.Entities:
Keywords: biological activities; extraction and purification; polysaccharides; structure; traditional Chinese medicines
Year: 2022 PMID: 36159471 PMCID: PMC9505017 DOI: 10.3389/fnut.2022.1005181
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1The schematic diagram of extraction and purification methods, structural characterization, chemical modification, and biological activities of TCMPs.
Extraction, purification, structural characterization, biological activities of polysaccharides from traditional Chinese medicines.
|
|
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Black mulberry fruit | HWE | 11.86% ± 0.21% | DEAE-52, | BMP-1-1 | 615 | Man, Rha, GlcA, Gal, Ara | FT–IR, HPGPC | NO | Antioxidant | ( |
| BMP-2-1 | 405 | Rha, GlcA, GalA, Gal, Ara | ||||||||
|
| HWE | 2.23 g/100 g | Anion-exchange chromatography | TPs-0 | ND | Rha, Glu, Gal, Ara, Xyl, galacturonic acid, and glucuronic acid | GC, GC-MS, NMR | α-Araf- (1 → 4) -α-Glcp- (1 → 3) -α-Arap- (1 → 3) -β-Galp- (1 → 3,6) -α-Galp- (1 → 5) -α-Araf- (1 → 3) -β-Galp- (1 → R | Antioxidant | ( |
| TPs-1 | ||||||||||
| TPs-2 | ||||||||||
| TPs-3 | ||||||||||
|
| HWE | 13.31% ± 0.08% | DEAE glucan gel A-25 | LGPs | 17.12 | Rha, Fuc, Xyl, Man Glu, Gal = | UV, FT–IR, GC, HPGPC, NMR | NO | Antioxidant | ( |
|
| HWE | ND | Sephadex G-50 | ASP | 80 | GlcA:Glc:Ara:Gal | UV, FT–IR, HPGPC | NO | Anti-tumor | ( |
| Longan fruit Pericarp | HWE | ND | Sephadex G-100 | PLFP | 420 | Ara:Glc:Gal:GalA = 32.8:17.6:33.7:15 | HPGPC, GC, GC–MS, FT–IR, NMR, Methylation | → 5)-l-Araf-(1 →, → 6)-d-Glcp-(1 → | ( | |
| Longan pulp | HWE | ND | IEC, GFC | LPIIa | 44.7 | ND | HPGPC, GC, GC–MS, FT–IR, NMR, Methylation | → 6)-Glc-(1 →, → 5)-Ara-(1 →, → 4)-Man-(1 → and → 6)-Gal-(1 →. | Immunomodulatory | ( |
|
| HWE | ND | Anion-exchange chromatography | SSP, SCP | ND | Ara, Glc, Gal | HPGPC, FT–IR | ND | Antioxidant, | ( |
| Mulberry | UAE | 3.13% | Anion-exchange chromatography | MFP | ND | ND | FT-IR | ND | Antioxidant, | ( |
| Longan fruit pericarp | UAE | 15.41% | ND | PLFP | ND | ND | ND | ND | ND | ( |
|
| UAE | 3.53% | ND | GP | ND | ND | ND | ND | Antioxidant | ( |
|
| UAE | 6.46% ± 0.19% | DEAE-52, | Neutral | 1.7 | ND | FT–IR, HPGPC, Methylation analysis, NMR | (1 → 4)-β-D-Glcp with branching at O-2 of (1 → 2,4)-β-D-Glcp | Antioxidant, anti-tumor | ( |
|
| UAE | ND | DEAE-52, | LLPS-1 | 350.5 | Glc:Man = 1:2 | FT–IR, HPGPC | NO | Immunomodulatory | ( |
| LLPS-2 | 403.3 | Glc:Man = 1:1 | ||||||||
| LLPS-3 | 146.2 | Ara:Gal:Glc:Man = 2:2:2:1 | ||||||||
| UAE | 8.29% ± 0.18% | ND | ND | ND | ND | FT–IR | NO | Antioxidant, α-glucosidase activities | ( | |
| MAE | 19.9% ± 0.2% | AEC, GFC | TPPs-2-1 | 17.8 | GalA, Ara, Gal, Rha, Glc, | FT–IR, HPGPC, GC–MS | NO | Antioxidant | ( | |
| MAE | 12.31% | Anion exchange chromatography | EULP | 38.83 | Rha, Ara, Gal, Glu, Xyl, Man, glucuronic acid, and galacturonic acid = 7:4:6:14:1:2:3:1 | GC–MS, GC, FT–IR, HPGPC | NO | Antioxidant | ( | |
| MAE | 14.11% | DEAE-52, | SMP1 | 6.087 | Glu (1%), Gal (1.67%), | FT–IR, HPGPC, NMR | NO | Antioxidant | ( | |
|
| MAE | 15.75% | Anion exchange chromatography | FMTP | 1.288 | NO | UV, FT–IR, HPGPC | NO | Antioxidant | ( |
| Mulberry | EAA | ND | Anion exchange chromatography | MOS-1a | 0.987 | NO | UV, FT–IR, GC–MS, GPC | NO | NO | ( |
|
| EAE | 9.29% ± 0.31% | Anion exchange chromatography | COP | NO | NO | NO | NO | NO | ( |
|
| EAE | 29.96% ± 0.14% | ND | ND | ND | ND | ND | NO | Antioxidant | ( |
| Korean ginseng | EAE | ND | Anion exchange chromatography | FGWP | Rha, Ara, Gal galacturonic acid, Glu = 1.8:10.1:9.2:17.8:60.6 | UV, FT–IR, GC–MS, HPGPC | ND | Immunomodulatory | ( | |
| Alfalfa | EAE | 5.05% ± 0.02% | ND | ND | ND | ND | ND | ND | Antioxidant | ( |
|
| ATPE | 63.58% ± 1.12% | Anion exchange chromatography | C-PLPS | 15.2 | Ara, Xyl, Man, Glc, and Gal with the molar ratios of 1.0:1.5:3.4:25.2:1.1 | UV, FT–IR, HPGPC | ND | Antioxidant, antitumor | ( |
| ATPE | 24.79 mg/g | DEAE-52, | PTP-1 | ND | ND | FT–IR, UV | NO | Antioxidant | ( | |
| PTP-2 | ||||||||||
| PTP-3 | ||||||||||
|
| ATPE | 90.21% | Anion exchange chromatography | CGFP | 2,954 | Glu | FT–IR, AFM, HPGPC | NO | Antioxidant | ( |
|
| ATPE | 0.95 mg/g | NO | NO | NO | NO | NO | NO | NO | ( |
| Cornus officinalis fruit | UATPE | 7.85% ± 0.09% | DEAE-52 and Sephadex G-100 | COPs-4-SG | 33.64 | Galacturonic acid, Ara, Man, Glu, and Gala in a molar ratio of 34.82:14.19:6.75:13.48:12.26. | FT–IR, AFM, CD, HPGPC | NO | NO | ( |
| UATPE | 8.18% | Anion exchange chromatography | ZMP | NO | Rha, Ara, Xyl, Ma, Glu, Gal, and galacturonic acid with at the ratios of 1.46:2.47:2.27:1.12:1.00:1.57:5.40 | HPGPC, UV, FT–IR | NO | Antioxidant | ( | |
| UATPE | 36.58% | DEAE-52, | LPS | NO | NO | UV, FT–IR | NO | Antiglycation activity | ( | |
| UATPE | 15.17% ± 0.21% | DEAE-52, Sephadex G-100 | LLPs-2-SG | 421.41 | Man, Glu, and Gal in a molar ratio of 10.52:23.06:7.19 | UV, FT–IR, HPGPC, AFM, SEM | NO | NO | ( | |
| UAEE | 14.76% | DEAE-52, Sephadex G-100 | LJLP | NO | Gal (32.3%), Glu (20.9%), and Rib (15.2%) | UV–vis, FT–IR, HPGPC | NO | Antioxidant | ( | |
| UAEE | 29.75% ± 0.48% | Anion exchange chromatography | MCP | NO | NO | NO | NO | NO | ( | |
|
| UAEE | 4.33% ± 0.15% | Anion exchange chromatography | CMCP | NO | NO | NO | NO | Antioxidant | ( |
| Corn silk | UAEE | 4.56% | Anion exchange chromatography | CSPS | 105.2 | Rha, Ara, Xyl, Man, Gal = 4.17:17.33:5.59:18.65:19.11 | UV, FT–IR, HPGPC | NO | Antioxidant and anticancer activities | ( |
| UAEE | 40.56% | NO | NO | NO | NO | NO | NO | NO | ( | |
| UAEE | 16.64% | NO | NO | NO | NO | NO | NO | NO | ( | |
|
| HWE | 7.1% | DEAE-52 and Sephadex G-200 | OAP-1A | 593 | Man (35.7%), Glu (33.32%), Gal (19.6%), and Rha (11.38%) | GC–MS, NMR, FT–IR, HPGPC | → 3)-β-D-Manp-(1 →, → 3,4)-β-D-Manp-(1 →, → 3,6)-β-D-Manp-(1 →, → 3)-α-D-Glcp-(1 → α-D-Glcp-(1 → | Antioxidant | ( |
|
| HWE | NO | DEAE-52 and Sephadex G-150 | AGP | 2.89 | Rha: Ara:Xyl: Man: Glu: Gal with a molar ratio of 1:2.33:2.85:0.69:3.05:1.54 | GC–MS, periodate oxidation, Smith degradation, FT–IR, methylation, NMR | → 6)-β-d-Glcp-(→ backbone | α-glucosidase inhibition activity | ( |
|
| HWE | NO | diethylaminoethyl-cellulose and Sephacryl S-500 chromatography | LJP12 | 2.31 | Ara:Xyl:Man:Glc:Gal = 1:0.17:1.54:2.64:0.18 | HPGPC, FT–IR, NMR | 1,4-linked and 1,3,6-linked | NO | ( |
|
| HWE | NO | DEAE-A25 | WPS-2-1 | 80 | Man:Rha:Fuc = 1.0:2.3:1.2 | HPGPC, UV, FT–IR, NMR, Smith degradation | A backbone of array by (1 → 4)-glycosidic linkages | NO | ( |
HWE, Hot water extraction; UAE, Ultrasound assisted extraction; MAE, Microwave assisted extraction; EAE, Enzyme assisted extraction; UHPAE, Ultra-high pressure assisted extraction; ATPE, Aqueous two-phase extraction; UATPE, Ultrasound assisted aqueous two-phase extraction; UAEE, Ultrasound assisted enzyme extraction.
Figure 2Schematic diagram of different modification of TCMPs. (A) Sulfation modification; (B) acetylation modification; (C) carboxymethylation modification; (D) phosphorylation modification; (E) selenium modification.
Figure 3The main antioxidant and anti-aging mechanisms of TCMPs.
Figure 4The main immunomodulatory mechanism of TCMPs.
Figure 5The main hypoglycemic and hypolipidemic mechanisms of TCMPs.